The Babraham Investor Conference 2021 (BIC) is a virtual event for investors focusing on early-stage and scale-up life science and med-tech companies.
The Babraham Investor Conference is open to Investors only; if you would like to attend, please email firstname.lastname@example.org stating your name, company details and web address.
Our programme will feature a rich array of company presentations and digital networking opportunities. During the course of the day you can expect:
Martin Murphy is CEO of Syncona Investment Management Ltd. He co-founded Syncona in 2012 alongside the Wellcome Trust. Since then, Martin has been closely involved in the foundation and development of seven Syncona companies, including: Achilles Therapeutics, Autolus, OMass Therapeutics, Quell Therapeutics, Anaveon and Resolution Therapeutics. He was previously Chairman of Blue Earth Diagnostics, which Syncona sold to Bracco Imaging for $476 million in 2019. Previously, he was a partner at MVM Life Science Partners LLP, a venture capital company focused on life science and healthcare, where he led their European operations. Martin has also held roles with 3i Group plc and McKinsey & Company. He has a PhD in Biochemistry from the University of Cambridge.
Daniel Mahony is Co-Head of the Healthcare team at Polar Capital. He studied biochemistry at the University of Oxford and received his Ph.D. from the University of Cambridge. Daniel moved to California to work as a research scientist at Schering Plough Corporation (now Merck & Co.) in 1995 and made the transition into financial services in 1998, working for ING Barings in New York and Morgan Stanley in London as head of the European healthcare research team. In 2007, he set up Polar Capital’s healthcare team. He has over 29 years of experience within global healthcare covering sectors including biotechnology, medical technology and healthcare services.
Handelsbanken is a full-service bank with a decentralised way of working, a strong local presence due to a nationwide network of over 200 branches and a long-term approach to customer relations.
(+44) 1223 496 000
Babraham Bioscience Technologies Ltd
Babraham Research Campus
CB22 3AT, United Kingdom
01223 813 557